Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Status:
Completed
Trial end date:
2019-03-23
Target enrollment:
Participant gender:
Summary
Clinicians commonly use artificial tears off label for treating contact lens (CL) discomfort
and the dry eye associated with CLs because new artificial tear formulations have the
potential to outperform the available CL rewetting drops. While off-label, McDonald et al.
have previously shown that using a common artificial tear, Systane Ultra, before and after CL
use is an effective means for treating daily disposable CL wears who have CL discomfort.
Recently, a new formulation of artificial tears, Systane Complete, was released to the
market. Systane Complete is a unique formulation that has combined elements from both Systane
Ultra (indicated for aqueous deficient dry eye) and Systane Balance (indicated for
evaporative dry eye) to create an artificial tear with an indication for aqueous deficient,
evaporative, and mixed (both aqueous deficient and evaporative) dry eye. Thus, the goal of
this study is to determine in a randomized clinical trial if Systane Complete is able to
effectively improve the symptoms of patients who have CL discomfort.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborators:
Alcon Research Lindenhurst Eye Physicians & Surgeons, PC Southern College of Optometry